Overview of cancer vaccines: considerations for development

Related Experiment Video

Updated: May 19, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Alex Kudrin1

  • 1koudrine@hotmail.com

Human Vaccines & Immunotherapeutics
|August 17, 2012
PubMed

Insights

Developing effective cancer immunotherapies requires addressing key regulatory and developmental challenges. A strategic approach focusing on antigen discovery, product development, and clinical trial design is crucial for success.

Area of Science:

  • Oncology
  • Immunology
  • Drug Development

Background:

  • Cancer immunotherapy has a high failure rate, with limited recent regulatory approvals.
  • Significant challenges exist in the regulatory and developmental pathways for cancer immunotherapeutics.

Purpose of the Study:

  • To identify major regulatory and developmental issues in cancer immunotherapeutics.
  • To propose a strategic framework for advancing cancer immunotherapeutic development.
  • To review the regulatory landscape for cancer vaccines globally.

Main Methods:

  • Literature review focusing on regulatory and developmental aspects of cancer immunotherapeutics.
  • Analysis of existing regulatory frameworks in the EU, US, Japan, and developing countries.
  • Examination of clinical trial design considerations for cancer vaccines.

Main Results:

  • A three-pillar development approach is proposed: antigen discovery platforms, product development strategies, and clinical development strategies.
  • The review outlines regulatory frameworks for cancer vaccines across different regions.
  • Specific challenges in designing and conducting clinical trials for cancer vaccines are discussed.

Conclusions:

  • A structured, multi-faceted approach is essential to overcome hurdles in cancer immunotherapy development.
  • Understanding and navigating global regulatory landscapes is critical for successful product commercialization.
  • Optimizing clinical trial design is paramount for demonstrating the efficacy and safety of cancer vaccines.

More Related Videos

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo07:33

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo

Published on: September 28, 2022

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...